VIEMED HEALTHCARE, INC.

For the period ended Dec 31, 2025. Filed Mar 4, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 4, 2026

VMD$8.98+0.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Income

VIEMED HEALTHCARE, INC.CONSOLIDATED STATEMENTS OF INCOME

(Expressed in thousands of U.S. Dollars, except share and per share amounts)

	Year Ended December 31,
	Note	2025	2024	2023
Revenue	2	$270,280	$224,257	$183,008
Cost of revenue		114,822	91,054	70,225
Gross profit		$155,458	$133,203	$112,783
Operating expenses
Selling, general and administrative		121,366	106,199	87,884
Research and development		3,017	3,068	2,782
Stock-based compensation	8	9,132	6,285	5,849
Depreciation and amortization		1,485	1,483	1,391
Loss (gain) on disposal of property and equipment		(2,239)	(1,905)	645
Other expense (income), net		(252)	173	(98)
Income from operations		$22,949	$17,900	$14,330
Non-operating income and expenses
Income (loss) from investments		—	(954)	485
Interest expense, net	6	(1,182)	(776)	(424)
Net income before taxes		21,767	16,170	14,391
Provision for income taxes	10	6,391	4,761	4,148
Net income		$15,376	$11,409	$10,243
Net income attributable to noncontrolling interest		442	144	—
Net income attributable to Viemed Healthcare, Inc.		$14,934	$11,265	$10,243
Net income per share
Basic	11	$0.38	$0.29	$0.27
Diluted	11	$0.37	$0.28	$0.25
Weighted average number of common shares outstanding:
Basic	11	38,895,228	38,754,893	38,354,071
Diluted	11	40,823,823	40,805,085	40,378,922

See accompanying notes to the consolidated financial statements
Page	F-5

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.